The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -11.76 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M 0.38 — flag raised, worth a closer lookWatch
- Earnings quality 87/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as MANNKIND CORP reports it. History and quarterly detail are in the app.
- Product Revenue$216.5M
- Royalty$128.1M
- Product$114.1M
- License And Service$106.7M
- Afrezza$74.6M
Leadership changes
From MANNKIND CORP's own filings, the day they're filed.
- Lauren Sabella · President · appointmenteff. 2025-07-18
- Burkhard Blank · Chief Medical Officer · departureeff. 2025-05-09
- Steven B. Binder · Chief Financial Officer · departureeff. 2024-04-22
Latest filings
- 8-K · Company announcement2026-08-21
- 8-K · Company announcement2026-08-05
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-07-24
- 8-K · Company announcement2026-06-02
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about MANNKIND CORP, every answer cited to the official filings🔒
- The Intelligence Brief — added when MANNKIND CORP's brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.